V Srinivasa Murthy

Title: V Srinivasa Murthy: Innovator in CNS Pharmacology

Introduction

V Srinivasa Murthy is an accomplished inventor based in Winston-Salem, North Carolina. He has made significant contributions to the field of pharmacology, particularly through his innovative work on compounds targeting neuronal nicotinic receptors in the central nervous system.

Latest Patents

Murthy holds a patent for "Sub-type selective amides of diazabicycloalkanes." This patent discloses a range of compounds and pharmaceutical compositions that exhibit selectivity for the neuronal nicotinic receptors, specifically the α4β2 subtype. These compounds are derived from certain heteroaryl carboxylic acids and diazabicycloalkanes. They show promise in treating various CNS disorders, as they can alter the number of nicotinic cholinergic receptors, exhibit neuroprotective effects, and do so without significant adverse side effects like increased blood pressure or gastrointestinal complications.

Career Highlights

V Srinivasa Murthy is affiliated with Targacept, Inc., a company known for its research and development in the field of neuroscience and pharmacological innovations. His work has positioned him as a notable figure in CNS research, contributing to advancements that may improve therapeutic interventions for patients.

Collaborations

Throughout his career, Murthy has collaborated with notable colleagues, including Anatoly A. Mazurov and Lan Miao. These partnerships have fostered a collaborative environment, enhancing the development of novel therapeutic approaches in their shared field of research.

Conclusion

V Srinivasa Murthy stands out as a pioneering inventor whose work is pivotal in advancing the understanding and treatment of CNS disorders. His dedication to innovation within pharmacology highlights the importance of research in developing effective therapies for challenging medical conditions.